KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Recursion Pharmaceuticals (RXRX) Current Leases (2020 - 2025)

Recursion Pharmaceuticals filings provide 6 years of Current Leases readings, the most recent being $12.7 million for Q4 2025.

  • On a quarterly basis, Current Leases fell 8.21% to $12.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $12.7 million, a 8.21% decrease, with the full-year FY2025 number at $12.7 million, down 8.21% from a year prior.
  • Current Leases hit $12.7 million in Q4 2025 for Recursion Pharmaceuticals, up from $11.5 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $13.8 million in Q4 2024 to a low of $499000.0 in Q1 2021.
  • Median Current Leases over the past 5 years was $6.1 million (2024), compared with a mean of $7.0 million.
  • Biggest five-year swings in Current Leases: soared 950.5% in 2022 and later decreased 8.21% in 2025.
  • Recursion Pharmaceuticals' Current Leases stood at $1.4 million in 2021, then soared by 320.34% to $6.0 million in 2022, then increased by 2.76% to $6.1 million in 2023, then skyrocketed by 125.56% to $13.8 million in 2024, then fell by 8.21% to $12.7 million in 2025.
  • The last three reported values for Current Leases were $12.7 million (Q4 2025), $11.5 million (Q3 2025), and $11.7 million (Q2 2025) per Business Quant data.